Olanzapine for Cancer Appetite Loss
Phase 2
66
about 1.5 years
18+
1 site in OR
What this study is about
This trial is testing if olanzapine helps manage appetite loss in people with advanced cancers like esophageal, lung, or colon cancer. Olanzapine is a medication that may stimulate appetite and improve quality of life.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Take Olanzapine
- 3.Take Placebo Administration
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
olanzapine
oral (Oral Tablet)
Secondary: Change in Weight, Incidence of adverse events, Patient Reported Quality of Life, Patient Reported Symptoms, Physical Function, Proportion of patients with ≥1 unplanned hospitalization
Oncology